HAL (France)
open access
Brain-Specific PP1/LRRK2 Interaction-Tageting Peptides as a Novel Strategy for Parkinson’s Disease Treatment
The LRRK2 kinase has emerged as a priority therapeutic target due to its welldocumented role in Parkinson-s diseases (PD). One of LRRK2's key partners is the phosphatase PP1, which dephosphorylates LRRK2. Therefore, modulating this protein/protein interaction represents a promising therapeutic strat
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Regulation between LRRK2 and PP2A signaling in cellular models of Parkinsons disease#267877
- Identification of peptides interfering with the PP2Ac And LRRK2 interaction#254242
- TMBIM6 enhances dopaminergic neuron survival by modulating the IRE1a pathway in Parkinson’s disease#225257
- From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein-Templated Synthesis#948961
- ReLink-PyB: an adapted REINVENT-based framework for non-DSM PfDHODH inhibitor discovery.#326931
Record · ID 1345968
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive